Wellington Management — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Asher Bio develops selective immunotherapy drugs that target specific immune cell types to promote beneficial effects while minimizing toxicity.
BiotechHealthtechMedical DevicesSan Francisco, US
Ivana Djuretic(Founder)inAndy Yeung(Founder)in
Co-investorsEmles Venture PartnersGoAhead VenturesMission Bay CapitalMission BiocapitalRA CapitalY Combinator+2 more
Healthcare company acquired by Mirum Pharmaceuticals, a former RiverVest portfolio company.
San Mateo, US
Keting Chu(Executive Officer, Director)Dajun Yang(Director)Nancy Hong(Director)Alon Lazarus(Director)William J. Rutter(Director)Ting Jia(Director)
Co-investorsFrazier Life SciencesRA CapitalRiverVest Venture PartnersHBM Healthcare InvestmentsNovo HoldingsT. Rowe Price
Scale provides high-quality training data, model evaluations, and full-stack AI systems for enterprises and governments to build and deploy AI applications.
AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareSan Francisco, US
Alexandr Wang(Co-founder & CEO)inLucy Guo(Co-founder)in
Co-investorsAccelAdit Ventures Management, LlcBeyond CapitalCheyenne VenturesCoatue ManagementElad Gil+33 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.